McKechnie Duncan
- SEC CIK
- 0002062139
In the past year, 4 open-market sale filings worth $5.66M and no purchases.
Current role at each company
- VRTX Vertex Pharmaceuticals IncEVP, Chief Commercial Officeras of Jul 7, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $5.66M
- 4 filings
- Net
- −$5.66M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists McKechnie Duncan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2026 (view filing)4:08 PM ET | Jul 2 | 5 days | McKechnie DuncanEVP, Chief Commercial Officer | SSale | −1.54K | $519.00 | −$799.8K | −12.3%11.0K after | 10b5-1 |
| Mar 13, 2026 (view filing) | Mar 11 | 2 days | McKechnie DuncanEVP, Chief Commercial Officer | SSale | −2.63K | $498.42 | −$1.31M | −17.4%12.5K after | 10b5-1 |
| Mar 6, 2026 (view filing) | Mar 4 | 2 days | McKechnie DuncanEVP, Chief Commercial Officer | SSale | −2.44K | $475.30 | −$1.16M | −13.9%15.1K after | 10b5-1 |
| Feb 26, 2026 (view filing) | Feb 25 | 1 day | McKechnie DuncanEVP, Chief Commercial Officer | SSale | −4.91K | $487.65 | −$2.39M | −21.9%17.6K after | 2 lots10b5-1 |